Actavis Can't Sell Generic Gralise After Depomed IP Trial
Actavis Elizabeth LLC is barred from producing and selling a generic version of timed-release Gralise after a New Jersey federal judge found that Actavis infringed several Depomed Inc. patents on the...To view the full article, register now.
Already a subscriber? Click here to view full article